Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Saudi Medical Journal

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 18327361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECTS OF COMBINING INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITOR AND RADICAL SCAVENGER DURING PORCINE BACTEREMIA

  2007cited by this paper
• Comparison of SPO2, hearth rate and body temperature values in abdominal compartment syndrome in a rat model with intraabdominal sepsis and intraabdominal hypertension.

  2006cited by this paper
• Inhibition of Inducible Nitric Oxide Synthase Prevents Hepatic, but Not Pulmonary, Injury Following Ischemia-Reperfusion of Rat Liver

  2006cited by this paper
• Inducible nitric oxide synthase mediates cytokine release: the time course in conscious and septic rats.

  2006cited by this paper
• PNEUMONIA AFTER CECAL LIGATION AND PUNCTURE: A CLINICALLY RELEVANT "TWO-HIT" MODEL OF SEPSIS

  2006cited by this paper
• Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia.

  2006cited by this paper
• Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression.

  2005cited by this paper
• Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

  2004cited by this paper
• [Nitric-oxide synthase inhibitor treatment in septic shock].

  2004cited by this paper
• [The role of nitric oxide in trauma and infection].

  2004cited by this paper
• Cytokine Cascade in Sepsis

  2003cited by this paper
• Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion

  2003cited by this paper
• Characterization of the Expression of Inducible Nitric Oxide Synthase in Rat and Human Liver During Hemorrhagic Shock

  2003cited by this paper
• Mechanism of immune dysfunction in sepsis: inducible nitric oxide-meditated alterations in p38 MAPK activation.

  2002cited by this paper
• Role of nitric oxide in acute lung inflammation: Lessons learned from the inducible nitric oxide synthase knockout mouse*

  2002cited by this paper
• Cytokine modulation in sepsis and septic shock

  2002cited by this paper
• Impaired fertility in female mice lacking urinary trypsin inhibitor.

  2001cited by this paper
• Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes.

  2001cited by this paper
• The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock.

  2001cited by this paper
• Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.

  2000cited by this paper
• Therapeutic Effects of Ulinastatin on Experimental Crescentic Glomerulonephritis in Rats

  2000cited by this paper
• Guanylate cyclase and the .NO/cGMP signaling pathway.

  1999cited by this paper
• Down-regulation of interleukin-8 gene expression in HL60 cell line by human Kunitz-type trypsin inhibitor.

  1995cited by this paper
• Characterization of the cellular binding site for the urinary trypsin inhibitor.

  1994cited by this paper

• Urinary Trypsin Inhibitor Protects Tight Junctions of Septic Pulmonary Capillary Endothelial Cells by Regulating the Functions of Macrophages

  2021cites this paper
• The Protection Effect of Ulinastatin on Freshwater Instillation-Induced Acute Lung Injury in Rabbits

  2021cites this paper
• Exogenous inter-α inhibitor proteins prevent cell death and improve ischemic stroke outcomes in mice.

  2021cites this paper
• Ulinastatin attenuates protamine-induced cardiotoxicity in rats by inhibiting tumor necrosis factor alpha

  2020cites this paper
• Ulinastatin attenuates protamine-induced cardiotoxicity in rats by inhibiting tumor necrosis factor alpha

  2020cites this paper
• Role of serine protease inhibitor, ulinastatin, in rat model of hepatic encephalopathy: aquaporin 4 molecular targeting and therapeutic implication

  2020cites this paper
• Effects of ulinastatin combined with mechanical ventilation on oxygen metabolism, inflammation and stress response and antioxidant capacity of ARDS

  2018cites this paper
• Ulinastatin Ameliorates Pulmonary Capillary Endothelial Permeability Induced by Sepsis Through Protection of Tight Junctions via Inhibition of TNF-α and Related Pathways

  2018cites this paper
• Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model.

  2013cites this paper
• Ulinastatin Suppresses Burn-Induced Lipid Peroxidation and Reduces Fluid Requirements in a Swine Model

  2013cites this paper
• The effects of ulinastatin on systemic inflammation, visceral vasopermeability and tissue water content in rats with scald injury.

  2013cites this paper
• Atypical Reactive Center Kunitz-Type Inhibitor from the Sea Anemone Heteractis crispa

  2012cites this paper
• Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain

  2010cites this paper
• Expression of heat shock protein 70 in lung tissues of acute paraquat poisoned rats and intervention of ulinastatin.

  2010cites this paper
• Altered plasma proteome during an early phase of peritonitis-induced sepsis.

  2009cites this paper